Citius Oncology Inc. (CTOR)
NASDAQ: CTOR
· Real-Time Price · USD
1.63
0.02 (1.24%)
At close: Aug 21, 2025, 3:59 PM
1.73
6.13%
After-hours: Aug 21, 2025, 06:14 PM EDT
Citius Oncology Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 |
Cash & Equivalents | 112.00 | 112.00 | 112.00 | 112.00 | 261.00 | 33.33K | 32.74K | 26.52K | 370.1K | 289.18K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 49.15M | 48.58M | 72.57M | 70.63M | 69.39M | 67.81M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40M | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 17.21M | 15.34M | 14.38M | 8.27M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 18.31M | 18.04M | 17.08M | 10.97M | 40.99K | 94.39K | 58.2K | 85.16K | 461.91K | 377.34K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 73.4M | 73.4M | 73.4M | 73.4M | n/a | n/a | n/a | 40M | n/a | n/a |
Total Long-Term Assets | 73.4M | 73.4M | 73.4M | 73.4M | 49.15M | 48.58M | 72.57M | 70.63M | 69.39M | 67.81M |
Total Assets | 91.71M | 91.44M | 90.48M | 84.37M | 49.19M | 48.68M | 72.62M | 70.71M | 69.85M | 68.19M |
Account Payables | 8.67M | 7.68M | 5.87M | 3.71M | n/a | 503.91K | 205.02K | 1.29M | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | 1.72M | 1.52M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 44.32M | n/a | n/a | 28.99M | 1.36M | 795.12K | 1.84M | -19.62M | 463.88K | 31.84K |
Total Current Liabilities | 52.99M | 49.74M | 43.4M | 32.7M | 3.08M | 2.82M | 2.05M | 1.17M | 463.88K | 31.84K |
Long-Term Debt | 3.8M | 3.8M | 3.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 1.58M | 1.44M | 1.3M | n/a | n/a | n/a |
Total Long-Term Liabilities | 6.32M | 6.06M | 5.79M | 5.53M | 1.58M | 1.44M | 1.3M | 1.15M | n/a | n/a |
Total Liabilities | 59.31M | 55.8M | 49.19M | 38.23M | 3.08M | 2.82M | 2.05M | 1.17M | 463.88K | 31.84K |
Total Debt | 3.8M | 3.8M | 3.8M | 3.8M | 1.72M | 1.52M | n/a | n/a | n/a | n/a |
Common Stock | 7.16K | 7.16K | 7.16K | 7.16K | 167.00 | 167.00 | 167.00 | 167.00 | 242.00 | 242.00 |
Retained Earnings | -59.04M | -53.67M | -45.94M | -39.28M | -3.04M | -2.46M | -1.99M | -1.08M | -2.21K | 345.27K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 32.4M | 35.64M | 41.29M | 46.14M | 46.11M | 45.86M | 70.58M | 69.54M | 69.39M | 68.16M |
Total Investments | n/a | n/a | n/a | n/a | 49.15M | 48.58M | 72.57M | 70.63M | 69.39M | 67.81M |